Skip to content

Genomics and Prognosis in GI Cancers

Explore the Correlation of Genomics and Prognosis in Alimentary Tract Cancers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05767697
Enrollment
1000
Registered
2023-03-14
Start date
2020-04-15
Completion date
2025-12-31
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GI Cancer, Liver Cancer

Brief summary

This study aims to collect biospecimens and explore the correlation of genomics and prognosis in alimentary tract cancers.

Detailed description

In this study, the investigators will collect clinical specimens of alimentary tract cancers and perform DNA and RNA analysis to identify genetic alterations for the development of a comprehensive somatic mutation databases and investigate their potential correlation with clinical, radiological and pathological variables. The genomics study included but not limited to target gene panel sequencing, whole exome sequencing, whole genome sequencing, bulk RNA sequencing, single cell RNA sequencing and metagenomics.

Interventions

None listed

Sponsors

National Cheng-Kung University Hospital
CollaboratorOTHER
National Health Research Institutes, Taiwan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum

Inclusion criteria

* Able to sign the informed consent * Age \>= 20 * Histology proved pancreatic cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, cholangiocarcinoma, colorectal cancer * Agree to provide tumor/normal tissue including but not limited to surgical specimen, biopsy, cytology specimen, bile, urine or stool * Agree to receive blood sampling 20ml at first time and 10ml during each follow-up (total sampling amount no more than 30ml per month)

Exclusion criteria

* Cannot cooperate with blood sampling

Design outcomes

Primary

MeasureTime frameDescription
Number of subjects who still survive at 1 year1 year1 year overall survival rate

Countries

Taiwan

Contacts

Primary ContactYung-Yeh Su, MD
yysu@nhri.edu.tw+886-6-7000123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026